Marinomed Biotech AG sell ReynadJ
Start price
27.04.25
/
0%
€11.70
Target price
27.04.26
€2.00
Performance (%)
56.84%
Price
07:37
?
Summary
This prediction is currently active. The price for Marinomed Biotech AG has massively increased, which is bad news for the SELL prediction by ReynadJ. This prediction currently runs until 27.04.26. The prediction end date can be changed by ReynadJ at any time. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Marinomed Biotech AG | - | - |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
According to ReynadJ what are the pros and cons of Marinomed Biotech AG for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Low dividend yield expected
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Comments by ReynadJ for this prediction
In the thread Marinomed Biotech AG diskutieren
Sell Marinomed Biotech AG
Kursziel gesetzt auf 2,0